Следене
Xin Ku
Xin Ku
Потвърден имейл адрес: tum.de
Заглавие
Позовавания
Позовавания
Година
A series of α-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIα catalytic activity
H Huang, Q Chen, X Ku, L Meng, L Lin, X Wang, C Zhu, Y Wang, Z Chen, ...
Journal of medicinal chemistry 53 (8), 3048-3064, 2010
2352010
ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method
J Gong, C Cai, X Liu, X Ku, H Jiang, D Gao, H Li
Bioinformatics 29 (14), 1827-1829, 2013
1992013
Optimized chemical proteomics assay for kinase inhibitor profiling
G Médard, F Pachl, B Ruprecht, S Klaeger, S Heinzlmeir, D Helm, H Qiao, ...
Journal of proteome research 14 (3), 1574-1586, 2015
1252015
Efficient Iron/Copper Cocatalyzed S-Arylations of Thiols with Aryl Halides
X Ku, H Huang, H Jiang, H Liu
Journal of combinatorial chemistry 11 (3), 338-340, 2009
732009
Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant
W Zhou, X Liu, Z Tu, L Zhang, X Ku, F Bai, Z Zhao, Y Xu, K Ding, H Li
Journal of medicinal chemistry 56 (20), 7821-7837, 2013
562013
Exosomal proteome analysis of human plasma to monitor sepsis progression
Y Xu, X Ku, C Wu, C Cai, J Tang, W Yan
Biochemical and biophysical research communications 499 (4), 856-861, 2018
282018
New affinity probe targeting VEGF receptors for kinase inhibitor selectivity profiling by chemical proteomics
X Ku, S Heinzlmeir, D Helm, G Médard, B Kuster
Journal of proteome research 13 (5), 2445-2452, 2014
202014
Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target
S Lechner, MIP Malgapo, C Grätz, RR Steimbach, A Baron, P Rüther, ...
Nature Chemical Biology 18 (8), 812-820, 2022
162022
Data‐independent acquisition‐based quantitative proteomic analysis reveals differences in host immune response of peripheral blood mononuclear cells to sepsis
Y Tong, X Ku, C Wu, J Liu, C Yang, W Tang, W Yan, J Tang
Scandinavian Journal of Immunology 89 (4), e12748, 2019
142019
A new chemical probe for quantitative proteomic profiling of fibroblast growth factor receptor and its inhibitors
X Ku, S Heinzlmeir, X Liu, G Médard, B Kuster
Journal of Proteomics 96, 44-55, 2014
132014
Comprehensive Map of the Artemisia annua Proteome and Quantification of Differential Protein Expression in Chemotypes Producing High versus Low Content of …
M Chen, T Yan, L Ji, Y Dong, S Sidoli, Z Yuan, C Cai, J Chen, Y Tang, ...
Proteomics 20 (10), 1900310, 2020
82020
Deciphering tissue‐based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors
X Ku, Q Sun, L Zhu, Z Gu, Y Han, N Xu, C Meng, X Yang, W Yan, W Fang
Molecular Oncology 14 (4), 721-741, 2020
72020
In-Depth Characterization of Mass Spectrometry-Based Proteomic Profiles Revealed Novel Signature Proteins Associated with Liver Metastatic Colorectal Cancers
X Ku, Y Xu, C Cai, Y Yang, L Cui, W Yan
Analytical Cellular Pathology 2019, 2019
72019
High temperature oxidation resistance of Ni-CeO2 nanocomposite coatings by pulse electrodeposition under ultrasound condition
YJ Xue, HB Liu, MM Lan, XC Ku, JX Li
Chinese Journal of Nonferrous Metals 20 (8), 1599-1604, 2010
72010
O-linked N-acetylgalactosamine modification is present on the tumor suppressor p53
Z Xu, X Ku, A Tomioka, W Xie, T Liang, X Zou, Y Cui, T Sato, H Kaji, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1864 (8), 129635, 2020
42020
Comprehensive analysis of O-glycosylation of amyloid precursor protein (APP) using targeted and multi-fragmentation MS strategy
J Shi, X Ku, X Zou, J Hou, W Yan, Y Zhang
Biochimica et Biophysica Acta (BBA)-General Subjects 1865 (10), 129954, 2021
32021
Investigation of an optimal lysis method for the study of thymus and thymoma by mass spectrometry-based proteomics
Q Sun, X Ku, N Xu, X Zhang, W Yan, W Fang
Transl Cancer Res 7, 391-400, 2018
32018
Leveraging Protein Dynamics to Identify Functional Phosphorylation Sites using Deep Learning Models
F Zhu, S Yang, F Meng, Y Zheng, X Ku, C Luo, G Hu, Z Liang
Journal of Chemical Information and Modeling 62 (14), 3331-3345, 2022
22022
Data independent acquisition-mass spectrometry (DIA-MS)-based comprehensive profiling of bone metastatic cancers revealed molecular fingerprints to assist clinical …
X Ku, C Cai, Y Xu, S Chen, Z Zhou, J Xiao, W Yan
Translational Cancer Research 9 (4), 2390, 2020
22020
Target deconvolution of HDAC pharmacopoeia highlights MBLAC2 as common off-target
S Lechner, M Malgapo, C Grätz, A Baron, PL Rüther, S Nadal, C Stumpf, ...
12021
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20